President Trump last week announced that he intends to nominate Stephen Hahn, CMO of MD Anderson Cancer Center in Houston, to serve as FDA commissioner. In addition, Brett Giroir, assistant secretary for health at HHS, has replaced Ned Sharpless as FDA’s acting commissioner until a permanent commissioner is confirmed. (Source: Washington Post, 11/1)
